A carregar...

Mixed Response to Immunotherapy in Patients with Metastatic Melanoma

BACKGROUND: Immunotherapy has improved overall survival in metastatic melanoma. Response to therapy can be difficult to evaluate as the traditionally used RECIST 1.1 criteria do not capture heterogeneous responses. Here we describe the clinical characterization of melanoma patients with a clinically...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Rauwerdink, Daan Jan Willem, Molina, George, Frederick, Dennie Tompers, Sharova, Tanya, van der Hage, Jos, Cohen, Sonia, Boland, Genevieve Marie
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410859/
https://ncbi.nlm.nih.gov/pubmed/32472413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08657-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!